Avacta Group plc announced that Shaun Chilton has joined the Board as a Non-executive Director. Shaun Chilton was most recently Chief Executive Officer of the formerly London-listed Clinigen Group plc ("Clinigen"), a global pharmaceutical and pharmaceutical services platform business, which he led through a significant growth journey. During his tenure, the company expanded through both an organic and a buy-and-build strategy which included successfully completing several transformational acquisitions.

The Company was eventually sold to Triton Partners for a total consideration of c.£1.3 billion in April 2022. Alongside his role as the CEO of Clinigen, Shaun was Non-Executive Chairman of C7Health, a disruptive, venture capital-backed medical technology and services business which executed an acquisitive growth journey before successfully being acquired by a strategic buyer in 2022.